Applicant, as named in the Orange Book

Paratek Pharms

Next listed expiry: Xhance on 23 Feb 2036. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xhance fluticasone propionate	fluticasone propionate	209022	23 Feb 2036	patent, carve-out possible
Nuzyra omadacycline tosylate	omadacycline tosylate	209816	31 Oct 2037	patent, carve-out possible
Nuzyra omadacycline tosylate	omadacycline tosylate	209817	31 Oct 2037	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.